Product Code: GVR-4-68039-996-9
Arterial Cannula Market Growth & Trends:
The global arterial cannula market size is projected to reach USD 33.4 million by 2030, registering a CAGR of 7.2% over theforecast period, according to a new report by Grand View Research. An increase in the prevalence of chronic diseases is leading to a rise in surgical procedures, which is driving the growth of the industry. According to an article published by the National Library of Medicine in September 2020, an overwhelming 310 million major surgeries are performed each year; around 20 million in Europe and about 40 to 50 million in the USA. Furthermore, advancements in minimally invasive surgeries are driving product demand. Minimally invasive techniques and cutting-edge technology give patients fast recovery time, less pain, and the best aesthetic results.
These advantages have resulted in the increasing adoption of minimally invasive techniques, which is leading to an increasing number of patients opting to undergo these surgical interventions. The COVID-19 pandemic resulted in a temporary fall in product sales. This is due to the postponement of elective surgeries to avoid the spread of the virus and focus dedicatedly on combatting the COVID-19 virus. However, the market began to quickly recover in the second half of the pandemic with increasing efforts of healthcare professionals and different strategies led down at the micro as well as macro-economic levels. The industry is further expected to experience significant demand over the forecast period with governments of various countries majorly focusing on healthcare to avoid similar situations in the future. Moreover, increasing investments in the healthcare sector are also expected to boost the overall industry growth over the forecast period.
Arterial Cannula Market Report Highlights:
- The ECMO segment held the highest revenue share in 2022 owing to the increasing adoption of the arterial cannula for oxygenation
- The cardiopulmonary bypass surgery segment is projected to experience the fastestCAGR over the forecast period due to the increasing prevalence of cardiac diseases
- The 20-22 Fr size segment led the market, in terms ofrevenue share in 2022 as these are the most commonly used arterial cannulas
- The hospitals segment held the largest share in 2022 as the majority of surgical procedures are carried out in these settings
- The ASCs segmentwill registerthe fastest growth rate over the forecast period due to favorable reimbursement initiatives by various governments
- North America was the largest region in 2022 owing to a well-developed healthcare structure and a significant patient pool
- Asia Pacific is expected to be the fastest-growing region over the forecast period due to the high prevalence of chronic diseases and the increasing geriatric population
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Application
- 1.1.2. Size
- 1.1.3. End-Use
- 1.1.4. Regional scope
- 1.1.5. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.3.5.1. Data for primary interviews in North America
- 1.3.5.2. Data for primary interviews in Europe
- 1.3.5.3. Data for primary interviews in Asia Pacific
- 1.3.5.4. Data for primary interviews in Latin America
- 1.3.5.5. Data for Primary interviews in MEA
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.2. Approach 1: Commodity flow approach
- 1.6.3. Volume price analysis (Model 2)
- 1.6.4. Approach 2: Volume price analysis
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
- 1.9.1. Objective 1
- 1.9.2. Objective 2
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Application Outlook
- 2.2.2. Size Outlook
- 2.2.3. End-use Outlook
- 2.2.4. Regional Outlook
- 2.3. Competitive Insights
Chapter 3. Arterial Cannula Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Industry Value Chain Analysis
- 3.3.1. Reimbursement framework
- 3.4. Market Dynamics
- 3.4.1. Market driver analysis
- 3.4.1.1. Increasing prevalence of chronic diseases
- 3.4.1.2. Increasing geriatric population
- 3.4.1.3. Rise in number of surgical procedures
- 3.4.1.4. Advancements in minimally invasive surgeries
- 3.4.2. Market restraint analysis
- 3.4.2.1. Lack of skilled professionals
- 3.4.2.2. Product recalls
- 3.5. Arterial Cannula Market Analysis Tools
- 3.5.1. Industry Analysis - Porter's
- 3.5.1.1. Supplier power
- 3.5.1.2. Buyer power
- 3.5.1.3. Substitution threat
- 3.5.1.4. Threat of new entrant
- 3.5.1.5. Competitive rivalry
- 3.5.2. PESTEL Analysis
- 3.5.2.1. Political landscape
- 3.5.2.2. Technological landscape
- 3.5.2.3. Economic landscape
- 3.5.3. Major Deals & Strategic Alliances Analysis
- 3.5.4. Market Entry Strategies
Chapter 4. Arterial Cannula Device: Application Estimates & Trend Analysis
- 4.1. Definitions and Scope
- 4.1.1. Cardiopulmonary Bypass Surgery
- 4.1.2. Extracorporeal Membrane Oxygenation (ECMO)
- 4.1.3. Others
- 4.2. Product Market Share, 2022 & 2030
- 4.3. Segment Dashboard
- 4.4. Global Arterial Cannula Market by Product Outlook
- 4.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
- 4.5.1. Cardiopulmonary Bypass Surgery
- 4.5.1.1. Market estimates and forecast 2017 - 2030 (Revenue in USD Million)
- 4.5.2. Extracorporeal Membrane Oxygenation (ECMO)
- 4.5.2.1. Market estimates and forecast, 2017 - 2030 (Revenue in USD Million)
- 4.5.3. Others
- 4.5.3.1. Market estimates and forecast, 2017 - 2030 (Revenue in USD Million)
Chapter 5. Arterial Cannula: Size Estimates & Trend Analysis
- 5.1. Definitions and Scope
- 5.1.1. 14-16 Fr
- 5.1.2. 17-19 Fr
- 5.1.3. 20-22 Fr
- 5.1.4. 23-25 Fr
- 5.1.5. 26-28 Fr
- 5.1.6. 29- 31 Fr
- 5.1.7. 32-34 Fr
- 5.1.8. 35-36 Fr
- 5.2. Size Market Share, 2022 & 2030
- 5.3. Segment Dashboard
- 5.4. Global Arterial Cannula Market by Application Outlook
- 5.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
- 5.5.1. 14-16 Fr
- 5.5.1.1. Market estimates and forecast, 2017 - 2030 (Revenue in USD Million)
- 5.5.2. 17-19 Fr
- 5.5.2.1. Market estimates and forecast, 2017 - 2030 (Revenue in USD Million)
- 5.5.3. 20-22 Fr
- 5.5.3.1. Market estimates and forecast, 2017 - 2030 (Revenue in USD Million)
- 5.5.4. 23-25 Fr
- 5.5.4.1. Market estimates and forecast, 2017 - 2030 (Revenue in USD Million)
- 5.5.5. 26-28 Fr
- 5.5.5.1. Market estimates and forecast, 2017 - 2030 (Revenue in USD Million)
- 5.5.6. 29-31 Fr
- 5.5.6.1. Market estimates and forecast, 2017 - 2030 (Revenue in USD Million)
- 5.5.7. 32-34 Fr
- 5.5.7.1. Market estimates and forecast, 2017 - 2030 (Revenue in USD Million)
- 5.5.8. 35-36 Fr
- 5.5.8.1. Market estimates and forecast, 2017 - 2030 (Revenue in USD Million)
Chapter 6. End - Use Estimates & Trend Analysis
- 6.1. Definitions and Scope
- 6.1.1. Hospitals
- 6.1.2. Ambulatory Surgical Centers
- 6.1.3. Others
- 6.2. End-Use Market Share, 2022 & 2030
- 6.3. Segment Dashboard
- 6.4. Global Arterial Cannula Market by End-Use Outlook
- 6.5. Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the following
- 6.5.1. Hospitals
- 6.5.1.1. Market estimates and forecast, 2017 - 2030 (Revenue in USD Million)
- 6.5.2. Ambulatory Surgical Centers
- 6.5.2.1. Market estimates and forecast, 2017 - 2030 (Revenue in USD Million)
- 6.5.3. Others
- 6.5.3.1. Market estimates and forecast, 2017 - 2030 (Revenue in USD Million)
Chapter 7. Arterial Cannula Market: Regional Estimates & Trend Analysis
- 7.1. Regional market share analysis, 2022 & 2030
- 7.2. Regional Market Dashboard
- 7.3. Global Regional Market Snapshot
- 7.4. Regional Market Share and Leading Players, 2022
- 7.4.1. North America
- 7.4.2. Europe
- 7.4.3. Asia Pacific
- 7.4.4. Latin America
- 7.4.5. Middle East and Africa
- 7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
- 7.5.1. North America
- 7.5.2. Europe
- 7.5.3. Asia Pacific
- 7.5.4. Latin America
- 7.5.5. Middle East and Africa
- 7.6. Market Size, & Forecasts and Trend Analysis, 2017 to 2030:
- 7.7. North America
- 7.7.1. Market estimates and forecast 2017 - 2030 (Revenue, USD Million)
- 7.7.2. U.S.
- 7.7.2.1. Market estimates and forecast 2017 - 2030 (Revenue, USD Million)
- 7.7.3. Canada
- 7.7.3.1. Market estimates and forecast 2017 - 2030 (Revenue, USD Million)
- 7.8. Europe
- 7.8.1. U.K.
- 7.8.1.1. Market estimates and forecast 2017 - 2030 (Revenue, USD Million)
- 7.8.2. Germany
- 7.8.2.1. Market estimates and forecast 2017 - 2030 (Revenue, USD Million)
- 7.8.3. France
- 7.8.3.1. Market estimates and forecast 2017 - 2030 (Revenue, USD Million)
- 7.8.4. Italy
- 7.8.4.1. Market estimates and forecast 2017 - 2030 (Revenue, USD Million)
- 7.8.5. Spain
- 7.8.5.1. Market estimates and forecast 2017 - 2030 (Revenue, USD Million)
- 7.9. Asia Pacific
- 7.9.1. Japan
- 7.9.1.1. Market estimates and forecast 2017 - 2030 (Revenue, USD Million)
- 7.9.2. China
- 7.9.2.1. Market estimates and forecast 2017 - 2030 (Revenue, USD Million)
- 7.9.3. India
- 7.9.3.1. Market estimates and forecast 2017 - 2030 (Revenue, USD Million)
- 7.10. Latin America
- 7.10.1. Brazil
- 7.10.1.1. Market estimates and forecast 2017 - 2030 (Revenue, USD Million)
- 7.10.2. Mexico
- 7.10.2.1. Market estimates and forecast 2017 - 2030 (Revenue, USD Million)
- 7.10.3. Argentina
- 7.10.3.1. Market estimates and forecast 2017 - 2030 (Revenue, USD Million)
- 7.11. MEA
- 7.11.1. South Africa
- 7.11.1.1. Market estimates and forecast 2017 - 2030 (Revenue, USD Million)
- 7.11.2. Saudi Arabia
- 7.11.2.1. Market estimates and forecast 2017 - 2030 (Revenue, USD Million)
- 7.11.3. UAE
- 7.11.3.1. Market estimates and forecast 2017 - 2030 (Revenue, USD Million)
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Company/Competition Categorization
- 8.2.1. Innovators
- 8.2.2. Market Leaders
- 8.2.3. Emerging Players
- 8.3. Vendor Landscape
- 8.3.1. List of key distributors and channel partners
- 8.3.2. Key customers
- 8.3.3. Key company market share analysis, 2022
- 8.3.4. Medtronic, plc.
- 8.3.4.1. Company overview
- 8.3.4.2. Financial performance
- 8.3.4.3. Product benchmarking
- 8.3.4.4. Strategic initiatives
- 8.3.5. LivaNova plc
- 8.3.5.1. Company overview
- 8.3.5.2. Financial performance
- 8.3.5.3. Product benchmarking
- 8.3.5.4. Strategic initiatives
- 8.3.6. Edward Lifesciences
- 8.3.6.1. Company overview
- 8.3.6.2. Financial performance
- 8.3.6.3. Product benchmarking
- 8.3.6.4. Strategic initiatives
- 8.3.7. Getinge AB
- 8.3.7.1. Company overview
- 8.3.7.2. Financial performance
- 8.3.7.3. Product benchmarking
- 8.3.7.4. Strategic initiatives
- 8.3.8. Fresenius Medical Care
- 8.3.8.1. Company overview
- 8.3.8.2. Financial performance
- 8.3.8.3. Product benchmarking
- 8.3.8.4. Strategic initiatives
- 8.3.9. BD
- 8.3.9.1. Company overview
- 8.3.9.2. Financial performance
- 8.3.9.3. Product benchmarking
- 8.3.9.4. Strategic initiatives
- 8.3.10. Nipro Corporation
- 8.3.10.1. Company overview
- 8.3.10.2. Financial performance
- 8.3.10.3. Product benchmarking
- 8.3.10.4. Strategic initiatives
- 8.3.11. Andocor
- 8.3.11.1. Company overview
- 8.3.11.2. Financial performance
- 8.3.11.3. Product benchmarking
- 8.3.11.4. Strategic initiatives
- 8.3.12. Freelife Medical GmbH
- 8.3.12.1. Company overview
- 8.3.12.2. Financial performance
- 8.3.12.3. Product benchmarking
- 8.3.12.4. Strategic initiatives
- 8.3.13. Surgical Holdings
- 8.3.13.1. Company overview
- 8.3.13.2. Financial performance
- 8.3.13.3. Product benchmarking
- 8.3.13.4. Strategic initiatives